Giuseppe Cabibbo MD, PhD
Giuseppe Cabibbo MD, PhD
Verified email at - Homepage
Cited by
Cited by
A meta‐analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma
G Cabibbo, M Enea, M Attanasio, J Bruix, A Craxė, C Cammā
Hepatology 51 (4), 1274-1283, 2010
Field‐practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy
M Iavarone, G Cabibbo, F Piscaglia, C Zavaglia, A Grieco, E Villa, ...
Hepatology, 2011
Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease
F Bortolotti, G Verucchi, C Cammā, G Cabibbo, L Zancan, G Indolfi, ...
Gastroenterology 134 (7), 1900-1907, 2008
Incidence of hepatocellular carcinoma in patients with HCV-associated cirrhosis treated with direct-acting antiviral agents
V Calvaruso, G Cabibbo, I Cacciola, S Petta, S Madonia, A Bellia, F Tinč, ...
Gastroenterology 155 (2), 411-421. e4, 2018
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study
E Villa, R Critelli, B Lei, G Marzocchi, C Cammā, G Giannelli, P Pontisso, ...
Gut 65 (5), 861-869, 2016
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study
A Vitale, P Burra, AC Frigo, F Trevisani, F Farinati, G Spolverato, M Volk, ...
Journal of hepatology 62 (3), 617-624, 2015
The impact of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data
F Fiorica, F Cartei, M Enea, A Licata, G Cabibbo, B Carau, A Liboni, ...
Cancer treatment reviews 33 (8), 729-740, 2007
Effects of eradicating hepatitis C virus infection in patients with cirrhosis differ with stage of portal hypertension
V Di Marco, V Calvaruso, D Ferraro, MG Bavetta, G Cabibbo, E Conte, ...
Gastroenterology 151 (1), 130-139. e2, 2016
Epidemiology, risk factors and surveillance of hepatocellular carcinoma
G Cabibbo, A Craxi
Eur Rev Med Pharmacol Sci 14 (4), 352-355, 2010
Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study
C Camma, V Di Marco, A Orlando, L Sandonato, A Casaril, P Parisi, ...
Journal of hepatology 42 (4), 535-540, 2005
Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population
S Bruno, V Di Marco, M Iavarone, L Roffi, A Crosignani, V Calvaruso, ...
Journal of Hepatology 64 (6), 1217-1223, 2016
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct‐acting antivirals? A prospective multicentre study
G Cabibbo, S Petta, V Calvaruso, I Cacciola, MR Cannavō, S Madonia, ...
Alimentary pharmacology & therapeutics 46 (7), 688-695, 2017
Natural history of untreatable hepatocellular carcinoma: a retrospective cohort study
G Cabibbo, M Maida, C Genco, P Parisi, M Peralta, M Antonucci, ...
World journal of hepatology 4 (9), 256, 2012
Staging systems of hepatocellular carcinoma: a review of literature
M Maida, E Orlando, C Cammā, G Cabibbo
World Journal of Gastroenterology: WJG 20 (15), 4141, 2014
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules
E Terzi, M Iavarone, M Pompili, L Veronese, G Cabibbo, M Fraquelli, ...
Journal of hepatology 68 (3), 485-492, 2018
Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma
A Cucchetti, F Trevisani, A Pecorelli, V Erroi, F Farinati, F Ciccarese, ...
Journal of Hepatology 61 (2), 333-341, 2014
Multimodal approaches to the treatment of hepatocellular carcinoma
G Cabibbo, F Latteri, M Antonucci, A Craxė
Nature Reviews Gastroenterology & Hepatology 6 (3), 159-169, 2009
Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems
C Camma, VD Marco, G Cabibbo, F Latteri, L Sandonato, P Parisi, ...
Alimentary pharmacology & therapeutics 28 (1), 62-75, 2008
Cost‐effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma
C Cammā, G Cabibbo, S Petta, M Enea, M Iavarone, A Grieco, ...
Hepatology 57 (3), 1046-1054, 2013
Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib
M Iavarone, G Cabibbo, M Biolato, C Della Corte, M Maida, M Barbara, ...
Hepatology 62 (3), 784-791, 2015
The system can't perform the operation now. Try again later.
Articles 1–20